No results for ‘’
Archit Organosys Ltd
₹67.90
(3.03%)
Thu, 17 Sept 2026, 02:46 am
Process Industries
Chemicals: Specialty
24.5KArchit Organosys EV/EBITDA Ratio
| Particulars | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 10.24 | 4.50 | 7.37 | 5.41 | 4.85 | 6.52 | 8.83 | 116.56 | 0 | 0 | 7.43 | 9.73 | 10.92 | 26.60 | 15.19 |
| Price to book ratio | 0 | 1.08 | 0.83 | 0.90 | 0.68 | 0.70 | 1.17 | 2.70 | 1.50 | 0.55 | 0.26 | 0.92 | 1.54 | 2.01 | 1.38 | 1.11 |
| Price to sales ratio | 0 | 0.08 | 0.07 | 0.10 | 0.07 | 0.07 | 0.19 | 0.32 | 0.73 | 0.23 | 0.11 | 0.39 | 0.59 | 0.97 | 0.78 | 0.61 |
| Price to cash flow ratio | 0 | 0 | 0 | 2.37 | 6.74 | 4.12 | 220.38 | 8.83 | 0 | 0 | 1.68 | 4.42 | 9.17 | 8.23 | 10.16 | 4.07 |
| Enterprise value | 0 | 11.07Cr | 11.57Cr | 10.48Cr | 10.1Cr | 11.92Cr | 19.71Cr | 46Cr | 94.52Cr | 51.35Cr | 40.4Cr | 64.09Cr | 109Cr | 150Cr | 111Cr | 104Cr |
| Enterprise value to EBITDA ratio | 0 | 9 | 7.86 | 4.84 | 6.28 | 5.85 | 6.84 | 16.46 | 29.62 | 0 | 12.30 | 5.76 | 6.37 | 7.61 | 15.80 | 8.01 |
| Debt to equity ratio | 2.47 | 2.95 | 3.03 | 1.72 | 1.56 | 1.62 | 0.85 | 1.18 | 0.91 | 1.06 | 1.02 | 0.76 | 0.65 | 0.51 | 0.41 | 0.40 |
| Return on equity % | 0 | 11.24 | 20.43 | 13.15 | 13.42 | 15.47 | 15.82 | 8.65 | 1.54 | -12.66 | -2.32 | 13.41 | 17.81 | 19.97 | 5.30 | 7.58 |
Archit Organosys Ltd Enterprise Value to EBITDA Ratio
The Archit Organosys Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Archit Organosys Ltd's valuation, profitability, and overall financial performance. Tracking the Archit Organosys Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Archit Organosys Ltd (NSE: , BSE: 524640) is currently trading at ₹67.90, with a market capitalization of ₹139.15Cr. As a leading company in the Process industries sector and Chemicals: specialty industry, monitoring the Archit Organosys Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Archit Organosys Ltd Enterprise Value to EBITDA Ratio Current Value
The current Archit Organosys Ltd Enterprise Value to EBITDA Ratio stands at 8.01.
The Archit Organosys Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Archit Organosys Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Archit Organosys Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 8.01
- 2023: 15.80
- 2022: 7.61
- 2021: 6.37
- 2020: 5.76
The decline in Archit Organosys Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.
What Archit Organosys Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Archit Organosys Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Archit Organosys Ltd.
Archit Organosys Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Archit Organosys Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Archit Organosys Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Archit Organosys Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.